Brief: Update -- Titan Pharmaceuticals Announces Licensing Deal With Ocular Therapeutix
12/12/2022 13:30
Dec 12 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* UPDATE -- TITAN PHARMACEUTICALS INC. ANNOUNCES LICENSING
AGREEMENT WITH OCULAR THERAPEUTIX INC.
* TITAN PHARMACEUTICALS - UNDER DEAL, OCULAR WILL PAY CO
UPFRONT
LICENSING FEE WITH POTENTIAL FOR ADDITIONAL PAYMENTS UPON
REACHING CERTAIN MILESTONES
Source text for Eikon: ID:nGNXbdgYY2
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.